Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than a buck. -- Ignore unavailable to you. Want to Upgrade?

To: RWReeves who wrote (526)	4/6/2000 11:17:00 PM
From: RWReeves	Respond to of 743

WooooHoooooo! LTAB right in there with the protein/genomics recovery. AICX +50% ERGO+40% Portfolio up 8% on the day. siliconinvestor.com Nice moves in Canadian small cap too like NVBTF and ALRXF, post AACR no doubt. I can buy and hold these darlin's forever, they held up pretty well in the meltdown. Limit to buy 25K shares CIST at 0.50. See if we can pick them up. Got some earlier in the week around this price. RWR

To: RWReeves who wrote (526)	4/7/2000 12:08:00 AM
From: RWReeves	Read Replies (1) \| Respond to of 743

CIST: At 20.85 million shares out, and the deal worth 18 million that's 90 cents a share for CIST. You get about .022 shares of CLL at 40 bucks per share for CLL(average 5 day trailing price through 20 March estimated by eyeball) for each share of CIST. The additional IL-1 options are each worth another 17-18 cents per share of CIST, if both get pulled down the value is 1.25 per share for CIST in total (.90+.35). CIST closed at half this today. Who is going to vote against it? CIST shareholders? Not Likely. CLL shareholders. Also not likely. Government agencies? I doubt any care. So it looks like a moving deal. Done no DD on whether AVE will pull down the options. RWR